In Brief: Forest Infasurf
Executive Summary
Forest Infasurf: FDA will accept Forest's NDA for the lung surfactant Infasurf, Forest says. FDA initially had determined that Infasurf is the same drug as Abbott's Survanta, which has orphan drug protection. Based on "new information" to be submitted by Forest, "FDA indicated that it will accept the NDA for filing," the company says...